SpaceX's $40 Billion Chip Lease Comes With a Louisiana Lawsuit and a Tesla Question Mark
Wedbush cuts target for BioCryst stock from USD 20.00 to USD 18.00
UBS sets USD 53.00 target for Nektar Therapeutics stock
Oppenheimer sets USD 50 target for Kratos Defense stock
Susquehanna lifts target to USD 58.00 for APA Corporation stock
PacBio schedules November 4 results for Pacific Biosciences stock
ATB Cormark sets USD 30.00 target for Riot Platforms stock
Hormel Foods will report fiscal 2026 results December 2: Hormel Foods stock yields 5.56 percent
MarketBeat cites USD 202.38 consensus for Okta stock
Amneal Pharmaceuticals stock hits a USD 21.46 52-week high
Liquidia schedules November 2 results. Liquidia stock costs EUR 40.77 after hours
UBS cuts target for Alnylam Pharmaceuticals stock from USD 550.00 to USD 354.00
Roku schedules November 2 results for Roku stock
J.P. Morgan raises CVR Energy target to USD 47.00 for CVR Energy stock
Curis stock gains 3.37 percent to EUR 0.35: MarketBeat estimates a November 5 report
IonQ sets November 5 results date for IonQ stock
RBC keeps CAD 4,400 target for Constellation Software stock
International Paper sets October 28 results date. International Paper stock gains 1.01 percent
Cameco stock gains 4.85 percent ahead of October 30 results
Cantor Fitzgerald sets USD 18 target for Novavax stock
BlackBerry stock trades at a 75.08 price-to-earnings ratio
BofA cuts target for PSEG stock from USD 87.00 to USD 85.00
American Airlines stock gains 3.76 percent above its Xetra close
Truist raises target for PayPal stock to USD 58.00
SAP's Orbital AI Pitch Meets a Down-to-Earth Question: Will the Cloud Deliver?
Europe's Machine Guarding Rules Get a Hard Deadline: January 19, 2027
Mosaic Company stock gains 4.99 percent to EUR 16.84 after hours
UBS cuts target to USD 3.25 for The Children's Place stock
Carnival Corp stock gains 3.62 percent to EUR 24.89
Jinko Holdings stock gains 3.31 percent versus Tradegate close
Cerence schedules November 23 results for Cerence stock
CIBC cuts Mercer International stock rating and sets USD 0.15 target
Wedbush cuts target for Denali Therapeutics stock from USD 27 to USD 23